Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders
RecruitingNCT06112067Phase: NAStarted 2023-10-16
Summary
This is a multi-center, single arm, prospective, open-label, extendable study for the efficacy and safety of combo-stim deep brain stimulation for treatment-refractory mental disorders (obsessive-comp
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
65 Years
Locations
Shanghai Mental Health CenterShanghai, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06112067